Eledon Pharmaceuticals, Inc. (ELDN)
1.78
-0.12
(-6.32%)
USD |
NASDAQ |
Nov 20, 16:00
1.81
+0.03
(+1.69%)
After-Hours: 20:00
Eledon Pharmaceuticals Price to Book Value : 4.707 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 4.707 |
| November 19, 2026 | 5.025 |
| November 18, 2026 | 5.368 |
| November 17, 2026 | 5.236 |
| November 16, 2026 | 5.210 |
| November 13, 2026 | 5.593 |
| November 12, 2026 | 6.254 |
| November 11, 2026 | 7.061 |
| November 10, 2026 | 7.299 |
| November 09, 2026 | 7.59 |
| November 06, 2026 | 6.889 |
| November 05, 2026 | 6.506 |
| November 04, 2026 | 7.140 |
| November 03, 2026 | 6.929 |
| November 02, 2026 | 6.929 |
| October 30, 2026 | 7.326 |
| October 29, 2026 | 8.040 |
| October 28, 2026 | 7.299 |
| October 27, 2026 | 6.374 |
| October 26, 2026 | 5.845 |
| October 23, 2026 | 6.083 |
| October 22, 2026 | 6.083 |
| October 21, 2026 | 5.977 |
| October 20, 2026 | 5.964 |
| October 19, 2026 | 5.712 |
| Date | Value |
|---|---|
| October 16, 2026 | 5.633 |
| October 15, 2026 | 6.003 |
| October 14, 2026 | 5.950 |
| October 13, 2026 | 6.188 |
| October 12, 2026 | 6.453 |
| October 09, 2026 | 6.559 |
| October 08, 2026 | 6.400 |
| October 07, 2026 | 6.400 |
| October 06, 2026 | 6.479 |
| October 05, 2026 | 6.612 |
| October 02, 2026 | 6.585 |
| October 01, 2026 | 6.440 |
| September 30, 2026 | 6.691 |
| September 29, 2026 | 6.126 |
| September 28, 2026 | 6.469 |
| September 25, 2026 | 6.493 |
| September 24, 2026 | 6.567 |
| September 23, 2026 | 6.665 |
| September 22, 2026 | 7.081 |
| September 21, 2026 | 6.591 |
| September 18, 2026 | 6.420 |
| September 17, 2026 | 6.493 |
| September 16, 2026 | 6.542 |
| September 15, 2026 | 6.640 |
| September 14, 2026 | 6.787 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| Price | 1.78 |
| Earnings Yield | -44.85% |
| Market Cap | 144.97M |